Belite Bio, Inc (BLTE)

Profile

Full Name

Belite Bio, Inc

Ticker

NASDAQ: BLTE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 29, 2022

Indexes

Not included

Website

http://www.belitebio.com

Employees

25

Key Details

Price

$65.01(+0.31%)

Market cap

$2.12B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.18(+0.84% YoY)

PE ratio

-

Next earnings date

Aug 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $65.01
    BLTE price is $65.01

    30-Day Relative Volume

    0.80
    BLTE 30-day relative volume is 0.80

    Price Performance

    Price Today change

    +0.31%
    BLTE price is up +0.31% today

    Price YTD change

    +3.03%
    BLTE price is up +3.03% since January 1st

    Price 1-year change

    +31.33%
    BLTE price is up +31.33% year-on-year

    Price 3-year change

    +93.48%
    BLTE price is up +93.48% over the past 3 years

    Price Range

    Price All-time high

    $86.53
    BLTE price is currently -24.87% below its historical high of $86.53

    Price 3-year low

    $11.00
    BLTE price is currently +491.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.12B
    BLTE market capitalization is $2.12 billion

    Market cap 3-year change

    +153.22%
    BLTE market capitalization is up +153.22% over the past 3 years

    Market cap All-time high

    $2.58B
    BLTE market capitalization is currently -18.10% below its historical high of $2.58 billion

    Market cap sector rank

    82.84%
    BLTE market capitalization is higher than 82.84% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +6.31%
    BLTE shares outstanding is up +6.31% year-on-year

    Shares Outstanding 3-Year Change

    +30.87%
    BLTE shares outstanding is up +30.87% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.40
    BLTE beta is 0.40

    200-day SMA

    $62.79
    BLTE price is currently +3.53% above its 200-day simple moving average

    50-day SMA

    $61.79
    BLTE price is currently +5.21% above its 50-day simple moving average

    RSI

    60.86
    BLTE 14-day relative strength index is 60.86

    Volume

    0.80
    BLTE 30-day relative volume is 0.80

    ATR

    $1.97
    BLTE average true range is $1.97

    10-day Historical Volatility

    30.68%
    BLTE 10-day historical volatility is 30.68%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    BLTE annual revenue value is unknown

    Revenue Analysts estimate

    -
    BLTE annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    BLTE annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    BLTE annual revenue is unknown

    EPS

    EPS

    -$1.18
    BLTE annual earnings per share is -$1.18

    EPS Analysts estimate

    -$1.75
    BLTE annual earnings per share is currently -32.47% lower than the consensus analysts' forecast

    EPS 1-year change

    +0.84%
    BLTE annual earnings per share is up +0.84% year-on-year

    EPS Sector rank

    51.7%
    BLTE annual earnings per share is higher than 51.7% of companies in Healthcare sector

    Profit

    Gross profit

    -
    BLTE annual gross profit value is unknown

    Gross margin

    -
    BLTE annual gross profit margin value is unknown

    Operating profit

    -$40.00M
    BLTE annual operating income is -$40.00 million

    Operating margin

    -
    BLTE annual operating profit margin value is unknown

    Net income

    -$36.14M
    BLTE annual net profit is -$36.14 million

    Net margin

    -
    BLTE annual net profit margin value is unknown

    Expenses

    Total expenses

    $40.00M
    BLTE annual total expenses is $40.00 million

    Operating expenses

    $40.00M
    BLTE annual total operating expenses is $40.00 million

    Cost of goods sold

    -
    BLTE annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $10.06M
    BLTE annual SGA is $10.06 million

    Depreciation and amortization

    $449.00K
    BLTE annual depreciation & amortization is $449.00 thousand

    Interest expense

    $20.00K
    BLTE annual interest expense is $20.00 thousand

    Income tax

    $6000.00
    BLTE annual income tax is $6000.00

    EBIT & EBITDA

    EBIT

    -$36.12M
    BLTE annual earnings before interest & taxes is -$36.12 million

    EBITDA

    -$35.67M
    BLTE annual EBITDA is -$35.67 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $152.13M
    BLTE annual total assets is $152.13 million

    Non current assets

    $5.06M
    BLTE annual long term assets is $5.06 million

    Current assets

    $147.07M
    BLTE annual total current assets is $147.07 million

    Cash and cash equivalents

    $31.68M
    BLTE annual cash & cash equivalents is $31.68 million

    Accounts receivable

    -
    BLTE annual accounts receivable value is unknown

    Inventory

    -
    BLTE annual inventory value is unknown

    Liabilities

    Total liabilities

    $6.31M
    BLTE annual total liabilities is $6.31 million

    Long term liabilities

    $261.00K
    BLTE annual total long term liabilities is $261.00 thousand

    Current liabilities

    $6.05M
    BLTE annual total current liabilities is $6.05 million

    Accounts payable

    -
    BLTE annual accounts payable value is unknown

    Debt

    Total debt

    $537.00K
    BLTE annual total debt is $537.00 thousand

    Total debt 1-year change

    -39.39%
    BLTE annual total debt is down -39.39% year-on-year

    Long term debt

    $261.00K
    BLTE annual long term debt is $261.00 thousand

    Short term debt

    $276.00K
    BLTE annual short term debt is $276.00 thousand

    Equity & Capital

    Shareholders equity

    $145.82M
    BLTE annual stockholders equity is $145.82 million

    Book value

    $145.82M
    BLTE annual book value is $145.82 million

    Retained earnings

    -$107.65M
    BLTE annual retained earnings is -$107.65 million

    Working capital

    $141.02M
    BLTE annual working capital is $141.02 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$29.23M
    BLTE annual cash flow from operations is -$29.23 million

    Cash from operations 1-year change

    +2.02%
    BLTE annual cash flow from operations is up +2.02% year-on-year

    Cash from investing

    -$110.57M
    BLTE annual cash flow from investing activities is -$110.57 million

    Cash from investing 1-year change

    -175411.11%
    BLTE annual cash flow from investing activities is down -175411.11% year-on-year

    Cash from financing

    $83.59M
    BLTE annual cash flow from financing activities is $83.59 million

    Cash from financing 1-year change

    +10.05%
    BLTE annual cash flow from financing activities is up +10.05% year-on-year

    CAPEX

    CAPEX

    -
    BLTE annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    BLTE annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$29.39M
    BLTE annual free cash flow is -$29.39 million

    Free cash flow 1-year change

    +1.72%
    BLTE annual free cash flow is up +1.72% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    BLTE annual gross profit margin value is unknown

    Operating margin

    -
    BLTE annual operating profit margin value is unknown

    Net margin

    -
    BLTE annual net profit margin value is unknown

    ROA & ROE

    ROA

    -23.76%
    BLTE annual return on assets is -23.76%

    ROE

    -24.79%
    BLTE annual return on equity is -24.79%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BLTE price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BLTE price to earnings ratio is unknown

    PB Ratio

    PB ratio

    13.38
    BLTE price to book ratio is 13.38

    PB ratio Sector rank

    92.21%
    BLTE price to book ratio is higher than 92.21% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    BLTE price to sales ratio value is unknown

    PS ratio Sector rank

    -
    BLTE price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -
    BLTE enterprise value value is unknown

    Enterprise value Sector rank

    -
    BLTE enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -
    BLTE EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    BLTE EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    24.31
    BLTE annual current ratio is 24.31

    Quick ratio

    -
    BLTE annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    BLTE annual debt to equity ratio is 0.00

    Interest coverage ratio

    -1805.90
    BLTE annual interest coverage ratio is -1805.90

    Risk & Stability

    Piotroski F-Score

    -
    BLTE piotroski f-score value is unknown

    Altman Z-Score

    -
    BLTE altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Jul 3, 25 HC Wainwright & Co.
    Buy
    May 15, 25 HC Wainwright & Co.
    Buy
    May 15, 25 Cantor Fitzgerald
    Overweight
    Mar 26, 25 Benchmark
    Buy
    Mar 18, 25 HC Wainwright & Co.
    Buy
    Mar 18, 25 Cantor Fitzgerald
    Overweight
    Jan 21, 25 Benchmark
    Buy
    Nov 15, 24 Maxim Group
    Buy
    Nov 13, 24 HC Wainwright & Co.
    Buy
    Sep 12, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with BLTE included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Best performing stocks last month
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Belite Bio, Inc?
    • Does Belite Bio, Inc pay dividends?
    • What sector is Belite Bio, Inc in?
    • What industry is Belite Bio, Inc in?
    • What country is Belite Bio, Inc based in?
    • When did Belite Bio, Inc go public?
    • Is Belite Bio, Inc in the S&P 500?
    • Is Belite Bio, Inc in the NASDAQ 100?
    • Is Belite Bio, Inc in the Dow Jones?
    • When was Belite Bio, Inc's last earnings report?
    • When does Belite Bio, Inc report earnings?

    What is the ticker symbol for Belite Bio, Inc?

    The ticker symbol for Belite Bio, Inc is NASDAQ:BLTE

    Does Belite Bio, Inc pay dividends?

    No, Belite Bio, Inc does not pay dividends

    What sector is Belite Bio, Inc in?

    Belite Bio, Inc is in the Healthcare sector

    What industry is Belite Bio, Inc in?

    Belite Bio, Inc is in the Biotechnology industry

    What country is Belite Bio, Inc based in?

    Belite Bio, Inc is headquartered in United States

    When did Belite Bio, Inc go public?

    Belite Bio, Inc's initial public offering (IPO) was on April 29, 2022

    Is Belite Bio, Inc in the S&P 500?

    No, Belite Bio, Inc is not included in the S&P 500 index

    Is Belite Bio, Inc in the NASDAQ 100?

    No, Belite Bio, Inc is not included in the NASDAQ 100 index

    Is Belite Bio, Inc in the Dow Jones?

    No, Belite Bio, Inc is not included in the Dow Jones index

    When was Belite Bio, Inc's last earnings report?

    Belite Bio, Inc's most recent earnings report was on May 14, 2025

    When does Belite Bio, Inc report earnings?

    The next expected earnings date for Belite Bio, Inc is August 12, 2025
    On this page